Researchers Discover Gene Linked to Future Possibility of Human Limb Regeneration

A tiny salamander that can regrow an entire limb may have just revealed one of the biggest clues yet for future human regeneration therapies. Scientists studying axolotls, zebrafish, and mice have identified a shared group of genes that appear to control how damaged tissues regrow — a discovery that could eventually help researchers develop treatments for regenerating human limbs.

The study was published in the Proceedings of the National Academy of Sciences. The research team compared regeneration across three species known for their remarkable healing abilities: Mexican axolotl salamanders, zebrafish, and mice.

Axolotls can regrow entire limbs, tails, spinal cord tissue, and even parts of organs. Zebrafish can regenerate damaged fins, heart tissue, and parts of the nervous system. Mice, while far more limited, can still regrow the tips of injured digits — trait humans partially share under certain conditions.

Researchers discovered that all three species activated two genes, called SP6 and SP8, during regeneration. These genes became highly active in the epidermis, the outer tissue layer covering injured areas. The finding suggested that regeneration may rely on a shared biological program that exists across very different animals.

To test the role of these genes, scientists used CRISPR gene-editing technology to remove SP8 in axolotls. Without it, the salamanders failed to properly regrow limb bones. Similar defects were observed in mice when SP6 and SP8 were disrupted.

The team then went a step further. Using a gene therapy approach based on zebrafish research, scientists delivered a signaling molecule called FGF8 into injured mouse tissue. The therapy stimulated bone regrowth and partially restored regenerative abilities in mice lacking the SP genes.

Researchers caution that human limb regeneration remains far from reality. Still, the study offers strong evidence that universal genetic programs may control tissue regrowth across species. Scientists believe future therapies could one day mimic these pathways to repair severe injuries, improve recovery after amputations, and potentially restore lost function in humans.

REFERENCE: David A. Brown, Katja K. Koll, Erin Brush, Grant Darner, Timothy Curtis, Thomas Dvergsten, Melissa Tran, Colleen Milligan, David W. Wolfson, Trevor J. Gonzalez, Sydney Jeffs, Alyssa Ehrhardt, Rochelle Bitolas, Madeleine Landau, Kendall Reitz, David S. Salven, Leslie A. Slota-Burtt, Isabel Snee, Elena Singer-Freeman, Sayuri Bhatia, Jianhong Ou, Aravind Asokan, Joshua D. Currie, Kenneth D. Poss. Enhancer-directed gene delivery for digit regeneration based on conserved epidermal factors. Proceedings of the National Academy of Sciences, 2026; 123 (17) DOI: 10.1073/pnas.2532804123